Financial Statements

Bayer Group Consolidated Statements of Cash Flows

    [Table 25]
 2nd Quarter 20142nd Quarter 20151st Half 20141st Half 2015
 € million€ million€ million€ million
Income from continuing operations after income taxes9191,1412,3172,405
Income taxes343405851811
Financial result173287332561
Income taxes paid or accrued(395)(440)(935)(1,073)
Depreciation, amortization and impairments7008151,3451,616
Change in pension provisions(69)(36)(185)(123)
(Gains) losses on retirements of noncurrent assets(6)1(42)(13)
Gross cash flow1,6652,1733,6834,184
     
Decrease (increase) in inventories27(212)(312)(151)
Decrease (increase) in trade accounts receivable183(93)(1,707)(2,042)
(Decrease) increase in trade accounts payable(68)144(384)(347)
Changes in other working capital, other non-cash items(238)(62)433983
Net cash provided by (used in) operating activities (net cash flow), continuing operations1,5691,9501,7132,627
Net cash provided by (used in) operating activities (net cash flow), discontinued operations3295156
Net cash provided by (used in) operating activities (net cash flow) (total)1,6011,9591,7642,683
     
Cash outflows for additions to property, plant, equipment and intangible assets(529)(601)(886)(946)
Cash inflows from the sale of property, plant, equipment and other assets35595184
Cash inflows from divestitures66
Cash inflows from (outflows for) noncurrent financial assets(62)(77)(66)(336)
Cash outflows for acquisitions less acquired cash36(1,857)3
Interest and dividends received33574968
Cash inflows from (outflows for) current financial assets(1)64
Net cash provided by (used in) investing activities (total)(517)(527)(2,697)(1,123)
     
Dividend payments and withholding tax on dividends(1,737)(1,861)(1,737)(1,866)
Issuances of debt2,3784,6816,8337,202
Retirements of debt(3,083)(2,332)(4,460)(5,176)
Interest paid including interest-rate swaps(105)(195)(166)(287)
Interest received from interest-rate swaps40414351
Cash outflows for the purchase of additional interests in subsidiaries(1)
Net cash provided by (used in) financing activities (total)(2,507)334512(76)
     
Change in cash and cash equivalents due to business activities (total)(1,423)1,766(421)1,484
     
Cash and cash equivalents at beginning of period2,6311,6071,6621,853
     
Change in cash and cash equivalents due to changes in scope of consolidation3
Change in cash and cash equivalents due to exchange rate movements20(126)(13)(93)
     
Cash and cash equivalents at end of period1,2283,2471,2283,247
Last updated: July 29, 2015  Copyright © Bayer AG
http://www.quarterly-report-2015-q2.bayer.com